Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aimed to evaluate the association between baseline serum 25-hydroxyvitamin D [25(OH)D] levels and prognosis in BPPV.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This retrospective cohort study consecutively enrolled patients diagnosed with BPPV at our institution between January 2021 and December 2025.
Source: Methods.
Patients were excluded if they had suspected central positional vertigo or other central nervous system disorders, alternative vestibular disorders (including Ménière’s disease, vestibular neuritis, or vestibular migraine), active middle or inner ear infection, a history of otologic surgery, pregnancy or lactation, malignancy, severe hepatic or renal dysfunction, or disorders of calcium: phosphate metabolism (including hyperparathyroidism or hypoparathyroidism).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association between serum 25-hydroxyvitamin D levels and prognosis in benign paroxysmal positional vertigo
Cohort study · Frontiers in Nutrition · 2026
Original publication title
Association between serum 25-hydroxyvitamin D levels and prognosis in benign paroxysmal positional vertigo
Copyright © 2026 Rao and Guo.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Benign paroxysmal positional vertigo (BPPV) is a common peripheral vestibular disorder in which early nonresponse and recurrence remain clinically important. Vitamin D has been hypothesized to influence otoconial stability and inner-ear mineral homeostasis and may be associated with BPPV prognosis. This study aimed to evaluate the association between baseline serum 25-hydroxyvitamin D [25(OH)D] levels and prognosis in BPPV.
Source: BackgroundAbstract: What methods does the paper describe?
This retrospective cohort consecutively included 286 patients with BPPV diagnosed between January 2021 and December 2025. Baseline serum 25(OH)D was measured at initial presentation and categorized as deficiency (<20 ng/mL), insufficiency (20 to 29 ng/mL), or sufficiency (≥30 ng/mL). The primary outcome was 1-week short-term response, defined as complete symptom resolution plus conversion to a negative positional test after canalith repositioning. Secondary outcomes included repositioning maneuver burden, Dizziness Handicap Inventory (DHI) scores and change, and recurrence during follow-up. Multivariable logistic and linear regression models were used with stepwise adjustment.
Source: MethodsAbstract: Results
The overall 1-week response rate was 50.7%, with group-specific rates of 35.4% in the deficient group, 48.6% in the insufficient group, and 68.9% in the sufficient group (χ2 = 12.84, p = 0.002). Higher baseline serum 25(OH)D was independently associated with a greater likelihood of 1-week response (adjusted odds ratio per 5 ng/mL increase, 1.49; 95% confidence interval [CI], 1.20 to 1.85; p < 0.001). Among responders, vitamin D sufficiency was associated with lower odds of requiring multiple repositioning sessions than deficiency (adjusted odds ratio, 0.12; 95% CI, 0.03 to 0.48; p = 0.003).
Baseline and week-1 DHI differed across 25(OH)D categories, whereas change in DHI did not remain independently associated with 25(OH)D (β = 0.12; 95% CI, −0.17 to 0.41; p = 0.405). During follow-up of at least 3 months, recurrence occurred in 21.3% of patients, with rates of 33.3, 21.5, and 11.5% in the deficient, insufficient, and sufficient groups, respectively (χ2 = 7.65, p = 0.022).
Source: ResultsAbstract: Conclusion
Higher baseline serum 25(OH)D levels were associated with better short-term therapeutic response, lower repositioning burden, and lower recurrence proportion in BPPV. These findings suggest that baseline serum 25(OH)D may be relevant to prognostic stratification, but prospective studies are needed to clarify causality and clinical utility.
Source: ConclusionAuthors’ abstract
Background
Benign paroxysmal positional vertigo (BPPV) is a common peripheral vestibular disorder in which early nonresponse and recurrence remain clinically important. Vitamin D has been hypothesized to influence otoconial stability and inner-ear mineral homeostasis and may be associated with BPPV prognosis. This study aimed to evaluate the association between baseline serum 25-hydroxyvitamin D [25(OH)D] levels and prognosis in BPPV.
Methods
This retrospective cohort consecutively included 286 patients with BPPV diagnosed between January 2021 and December 2025. Baseline serum 25(OH)D was measured at initial presentation and categorized as deficiency (<20 ng/mL), insufficiency (20 to 29 ng/mL), or sufficiency (≥30 ng/mL). The primary outcome was 1-week short-term response, defined as complete symptom resolution plus conversion to a negative positional test after canalith repositioning. Secondary outcomes included repositioning maneuver burden, Dizziness Handicap Inventory (DHI) scores and change, and recurrence during follow-up. Multivariable logistic and linear regression models were used with stepwise adjustment.
Results
The overall 1-week response rate was 50.7%, with group-specific rates of 35.4% in the deficient group, 48.6% in the insufficient group, and 68.9% in the sufficient group (χ2 = 12.84, p = 0.002). Higher baseline serum 25(OH)D was independently associated with a greater likelihood of 1-week response (adjusted odds ratio per 5 ng/mL increase, 1.49; 95% confidence interval [CI], 1.20 to 1.85; p < 0.001). Among responders, vitamin D sufficiency was associated with lower odds of requiring multiple repositioning sessions than deficiency (adjusted odds ratio, 0.12; 95% CI, 0.03 to 0.48; p = 0.003).
Baseline and week-1 DHI differed across 25(OH)D categories, whereas change in DHI did not remain independently associated with 25(OH)D (β = 0.12; 95% CI, −0.17 to 0.41; p = 0.405). During follow-up of at least 3 months, recurrence occurred in 21.3% of patients, with rates of 33.3, 21.5, and 11.5% in the deficient, insufficient, and sufficient groups, respectively (χ2 = 7.65, p = 0.022).
Conclusion
Higher baseline serum 25(OH)D levels were associated with better short-term therapeutic response, lower repositioning burden, and lower recurrence proportion in BPPV. These findings suggest that baseline serum 25(OH)D may be relevant to prognostic stratification, but prospective studies are needed to clarify causality and clinical utility.
Publication and source details
Original title: Association between serum 25-hydroxyvitamin D levels and prognosis in benign paroxysmal positional vertigo
Zhen Rao; Rui Guo
Frontiers in Nutrition · 2026
* Correspondence: Rui Guo, GuoRui860908@163.comCopyright © 2026 Rao and Guo.2026Rao and Guohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the Science and Technology Innovation Program of Changde City (No. 2024ZD203).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-09T20:30:12.094568+00:00
DOI: 10.3389/fnut.2026.1805821 · PMC13275238